Company profile: EirGen Pharma
1.1 - Company Overview
Company description
- Provider of high potency oral solid dose medicines for human and veterinary use and contract development, manufacturing, and packaging services for the global pharmaceutical market, including research, formulation, and analytical development and investigational medicinal products. Fully licensed to manufacture oncology, cytotoxic, steroidal, and immunosuppressant molecules in purpose-built high containment suites, covering film-coated tablets, soft-gel, and hard-shell capsules.
Products and services
- Contract Development and Manufacturing Services: Delivers drug development, manufacturing, and packaging of investigational products for high potency oral solid dose therapies in a high containment facility licensed for oncology, cytotoxic, steroidal, and immunosuppressant molecules
- Contract Manufacturing: Supplies contract manufacturing for oral solid dose products in manufacturing suites, handling high barrier-to-entry medicines across licensed oncology, cytotoxic, steroidal, and immunosuppressant molecules
- High Potency Oral Solid Dose (OSD) Medicines: Produces high potency oral solid dose medicines for human and veterinary use, spanning oncology, cytotoxic, steroidal, and immunosuppressant molecules in a high-containment facility
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EirGen Pharma
Biodextris
HQ: Canada
Website
- Description: Provider of analytical and process development, early-phase clinical manufacturing, packaging, and scalable bioproduction services for vaccines and biologics. Offers quality control testing and validation to ensure regulatory compliance, with tailored development solutions for biotech and pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biodextris company profile →
Impopharma
HQ: Canada
Website
- Description: Provider of comprehensive drug product formulation and process development, along with wide-ranging analytical testing services for the pharmaceutical industry, specializing in nasal and pulmonary drug products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Impopharma company profile →
Life Science Connect
HQ: United States
Website
- Description: Provider of life science content marketing and sales enablement services, offering the Templeton Customer Insights Platform for purchasing journey insights and content optimization; the Follow Your Buyer Methodology; custom newsletters; Enhanced Lead Intelligence (ELI) reports; and content services including creation and distribution via webinars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Life Science Connect company profile →
Chemineau
HQ: France
Website
- Description: Provider of contract manufacturing and development services for pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemineau company profile →
Hydra Biosciences
HQ: United States
Website
- Description: Provider of biopharmaceutical drug discovery and development leveraging novel ion channels to develop drugs for pain, inflammation, cardiovascular and other diseases, based in Cambridge, Massachusetts, utilizing proprietary high-throughput screening platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hydra Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EirGen Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EirGen Pharma
2.2 - Growth funds investing in similar companies to EirGen Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EirGen Pharma
4.2 - Public trading comparable groups for EirGen Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →